<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

World

Are patients losing access to their autoimmune drugs post-Roe?

27 July 2022

1:26 AM

27 July 2022

1:26 AM

I was legitimately worried when I saw a friend post that her daughter may lose access to an important drug used to treat her autoimmune disease. In the aftermath of Roe v. Wade being overturned by the Supreme Court, my friend said drugs such as Methotrexate and Mifepristone were being banned in some states because of their dual purposes as medicative abortion drugs.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close